{"id":"W2246539308","doi":"10.1200/jco.2007.25.18_suppl.8004","title":"Cyclophosphamide and fludarabine (CF) in advanced indolent lymphoma: Results from the ECOG/CALGB intergroup E1496 trial","year":2007,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cyclophosphamide; Fludarabine; Vincristine; Gastroenterology; Internal medicine; Randomized controlled trial; Randomization; Prednisone; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001586346,0.000534268,0.0009648349,0.0002038988,0.0001670723,0.0005859737,0.0004774093,0.0007988764,0.001884522],"category_scores_gemma":[0.001216941,0.0001385761,0.0008496062,0.0003106679,0.0003350283,0.0004442493,0.0003282906,0.001399628,0.0002718621],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004376134,"about_ca_system_score_gemma":0.0003560192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000701271,"about_ca_topic_score_gemma":0.00139254,"domain_scores_codex":[0.9994164,0.0004093279,0.00002757113,0.0000502514,0.00004193156,0.00005465042],"domain_scores_gemma":[0.9994369,0.000161003,0.0001382982,0.0000564957,0.0000275436,0.000179748],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8514756,0.00280999,0.01249648,0.001335647,0.001759919,0.0001719842,0.00009691843,0.002200394,0.006443246,0.0005105592,0.006447945,0.1142514],"study_design_scores_gemma":[0.8049513,0.1036449,0.07107341,0.0005046899,0.003361544,0.000725445,0.00009962406,0.002122199,0.001627244,0.001055335,0.01079029,0.00004401557],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845276,0.01029788,0.000222641,0.0007396854,0.0001355675,0.0004069486,0.0009093389,0.0000260643,0.00273427],"genre_scores_gemma":[0.991509,0.003189604,0.000498585,0.001243674,0.0001879611,0.0003637884,0.002055418,0.00001062772,0.0009413814],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001884522,"threshold_uncertainty_score":0.008389533,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07671177949783103,"score_gpt":0.4371444699198557,"score_spread":0.3604326904220246,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}